findmyKOL

Douglas Goodin

Basic profile

San Francisco VA Medical Center

ORCIDNPI
RegionSan Francisco, CA · WestSpecialtyNeurologyFocusNeurology
Last active 2021findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Douglas Goodin is a Neurology physician affiliated with San Francisco VA Medical Center. OpenAlex indexes 246 publications with 17,427 citations (h-index 67). By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
246publications

Distinct works indexed by OpenAlex, matched via ORCID.

17,427citations

Total citations across indexed works.

67h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

11 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    51%
    Gabapentinoids18.9%
    Gabapentin81%Pregabalin19%
    Part D<11 patients
    Potassium Channel Blocker7.5%
    Dalfampridine Er100%
    Part D13 patients

    + 7 more classes in this area

  • Cancer & immunology

    33.1%
    Other immunostimulants15.7%
    Copaxone68%Glatopa32%
    Part D<11 patients
    Sphingosine 1-phosphate Receptor Modulator10.8%
    Fingolimod59%Mayzent41%
    Part D<11 patients

    + 2 more classes in this area

  • Musculoskeletal

    13.4%
    gamma-Aminobutyric Acid-ergic Agonist13.4%
    Baclofen100%
    Part D20 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”